title: What immunosuppression should be used for old-to-old recipients?
abstract: Elderly patients receiving a kidney from old donors (old-to-old) are a growing population of transplant recipients. This population cumulates risks of complications due to the co-morbidities and the immunodeficiency state and the frailty of the recipients together with the kidney senescence of the donors. In this context, the choice of immunosuppression is complicated and must take into account some contradictory principles explaining why no consensus exists today.
authors.affiliation: Department of Nephrology, University Hospital La Cavale Blanche, European University of Brittany, Brest, France. Electronic address: yannick.lemeur@chu-brest.fr.
authors.forename: Yannick
authors.initials: Y
authors.lastname: Le Meur
mesh_terms: D000368:Aged; D000375:Aging / Q000276:immunology*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000276:immunology*; D016030:Kidney Transplantation; D018570:Risk Assessment; D012307:Risk Factors; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents